Great euphoria surrounded the cannabis space – and then cannabis stocks collapsed. However, the author of today’s article notes that “for the first time in more than two years, there […]
read more
3 Higher-Risk (But Not Penny Stock) Plays For Higher Potential Growth
For investors willing to take on a higher level of risk in exchange for a higher potential payout, but who don’t want to take on the level of risk associated […]
read more
Better Pick A COVID-19 Vaccine Play
When it comes to which of the two biotech stocks with COVID-19 vaccine candidates focused on in today’s article is the better pick going forward, especially for aggressive investors, the […]
read moreStock Pickers’ Summer Of Discontent?
After a period of optimism amid calmer trading conditions, the S&P 500 just experienced its biggest plunge since March’s brutal selloff, as the Fed warned of a long path to […]
read more
Electoral Options: How – And Why – Traders Are Pricing In A Lot Of Risk In Early November
Despite the rejuvenated “risk-on” tone in the market at the moment, today’s article notes that traders are pricing in a lot of risk at one particular point in time in […]
read more
Why Now May Be The Perfect Time To Buy This Biotech Stock – And Avoid This Other One
“A crucial aspect of success in investing in biotech stocks is that of timing,” notes the author of today’s article, who proceeds to examine one biotech stock where it appears […]
read more
Analysts Aren’t Polarized On These “Strong Buy” Healthcare Penny Stocks Offering “Outsized Upside Potential”
When it comes to the polarizing penny stock space, the author of today’s article acknowledges that the dilemma is the following: “How are investors supposed to separate the penny stocks […]
read more
Seeking Abnormal Returns In “The New Abnormal”
As uncertain as things are right now, the author of today’s article advises that there are several categories of companies that will move higher in the current stock market: companies […]
read more
For The Best In Biotech, Look To The Baker Brothers
Given the volatility associated with the industry, when picking biotech stocks it may make sense to look to the best for ideas – and when it comes to the biotech […]
read more
The Reasons (Including One “Hidden Factor”) Why This Biopharmaceutical Stock Has Nearly Doubled Since Mid-March
Shares of the commercial-stage biopharmaceutical company highlighted in today’s article have nearly doubled since mid-March. The biggest reason why? The debut of the company’s hot new migraine drug, which it […]
read more